venclexta
Company Information
AbbVie is a pharmaceutical company that discovers, develops, and markets medicines.
| Industries: | Pharmaceuticals and Life Sciences Information Technology Biotechnology Technology, Hardware and Equipment Government and Military Science and Engineering Manufacturing Industrial Corporate Supplies and Printing Health Care Aerospace and Defence Electrical Engineering Software | |
|---|---|---|
| Locations: | North Chicago Redwood City, Ca Irvine, Ca Deerfield, Il Worcester, Ma Madison, Nj Waco, Tx Londonderry, Nh Austin, Tx Roma, Tx Parsippany, Nj Cambridge, Ma Westport, Ct Washington, Dc Dundalk, Md Dublin Sligo Dundalk Westport Diegem Zürich Marlow Liverpool Antrim Claudy Markham Frankfurt Courbevoie Londonderry Derry Bridgewater Derry, Nm Lima San Juan Chorrillos Wiesbaden Bratislava Carnaxide Johannesburg Beirut Riga Pasig City Warsaw Montevideo Madrid Colombo Dhaka Tegucigalpa Zwolle Zagreb Singapore Shah Alam Dubai Stockholm Istanbul Sana'A City Jeddah Auckland Gordonvale Cairo Petaling Jaya Kingston, Jamaica Mexico City Manama Riyadh Guatemala City Upplands Väsby Bengaluru Shanghai Caracas Taipei Cochabamba Guaynabo, Pr Seoul Guarulhos Quito Mascot Jakarta Bangkok Las Rozas De Madrid Port Of Spain Budapest Colorado Moscow Fiumicino Vienna Belgrade Breda Amman Karachi Athens São Paulo Bucharest Ludwigshafen Lake Bluff | |
| crunchbase: | https://www.crunchbase.com/organization/abbvie | |
| twitter: | https://www.twitter.com/venclextahcp | |
| facebook: | https://www.facebook.com/abbvieglobal | |
| linkedin: | https://www.linkedin.com/company/abbvie | |
| homepage: | https://venclextahcp.com | |
| Phone: | +1 8002555162 | |
| customerservice@abbvie.com | ||
| Description: | VENCLEXTA® is an oral therapy for select AML, CLL, and SLL patients. It is indicated for the treatment of Acute Myeloid Leukemia (AML) and Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL). VENCLEXTA can cause rapid reduction in tu... | |
| Stock Code: | NYSE:ABBV | |
Employees
Trends
Last 4 weeks
Last 3 months
DivestingInvesting
Recent Events
News
Job Posting
Other News
See All news